HUP0201455A3 - Recombinant adenoviruses for the sodium/iodide symporter (nis) - Google Patents

Recombinant adenoviruses for the sodium/iodide symporter (nis)

Info

Publication number: HUP0201455A3
Authority: HU; Hungary
Prior art keywords: nis; sodium; recombinant adenoviruses; iodide symporter; symporter
Prior art date: 1999-06-11

Application number

HU0201455A

Other languages

English (en)

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-11

Filing date

2000-06-08

Publication date

2004-12-28

2000-06-08 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2002-08-28 Publication of HUP0201455A2 publication Critical patent/HUP0201455A2/hu

2004-12-28 Publication of HUP0201455A3 publication Critical patent/HUP0201455A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Wood Science & Technology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Virology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Microbiology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cell Biology (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

HU0201455A 1999-06-11 2000-06-08 Recombinant adenoviruses for the sodium/iodide symporter (nis) HUP0201455A3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9907449A FR2794771B1 (fr)	1999-06-11	1999-06-11	Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)

Publications (2)

Publication Number	Publication Date
HUP0201455A2 HUP0201455A2 (en)	2002-08-28
HUP0201455A3 true HUP0201455A3 (en)	2004-12-28

Family

ID=9546704

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0201455A HUP0201455A3 (en)	1999-06-11	2000-06-08	Recombinant adenoviruses for the sodium/iodide symporter (nis)

Country Status (13)

Country	Link
US (2)	US20100080775A1 (hu)
EP (1)	EP1187919B1 (hu)
JP (2)	JP2003501107A (hu)
KR (1)	KR100708949B1 (hu)
CN (1)	CN1259418C (hu)
AU (1)	AU782934B2 (hu)
CA (1)	CA2376735A1 (hu)
DE (1)	DE60037189T2 (hu)
FR (1)	FR2794771B1 (hu)
HU (1)	HUP0201455A3 (hu)
IL (1)	IL146182A0 (hu)
MX (1)	MXPA01012004A (hu)
WO (1)	WO2000076450A2 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2794771B1 (fr)	1999-06-11	2001-08-10	Aventis Pharma Sa	Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
US6586411B1 (en)	2000-08-16	2003-07-01	Mayo Foundation For Medical Education And Research	System for monitoring the location of transgenes
US6896881B1 (en)	1999-09-24	2005-05-24	Mayo Foundation For Medical Education And Research	Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
US7118740B1 (en)	2000-09-22	2006-10-10	Mayo Foundation For Medical Education And Research	Method for limiting the growth of cancer cells using an attenuated measles virus
FR2837492B1 (fr) *	2002-03-21	2007-07-20	Commissariat Energie Atomique	Transporteur apical d'iode et ses applications
CA2690627C (en) *	2007-06-15	2014-12-02	Genelux Corporation	Microorganisms for imaging and/or treatment of tumors
CN102344489B (zh) *	2010-08-05	2014-02-26	中国医药大学	经修饰的钠碘共同转运蛋白质及其应用
US9951117B2 (en)	2010-09-02	2018-04-24	Mayo Foundation For Medical Education And Research	Vesicular stomatitis viruses
ES2545357T3 (es)	2010-09-02	2015-09-10	Mayo Foundation For Medical Education And Research	Virus de la estomatitis vesicular
ES2733211T3 (es)	2011-04-15	2019-11-28	Genelux Corp	Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas
US8859256B2 (en)	2011-10-05	2014-10-14	Genelux Corporation	Method for detecting replication or colonization of a biological therapeutic
TWI583224B (zh) *	2015-03-12	2017-05-11	柯彥均	訊息之即時通訊方法
EP3390428B1 (en)	2016-02-23	2019-09-25	Salk Institute for Biological Studies	High throughput assay for measuring adenovirus replication kinetics
WO2017147269A1 (en)	2016-02-23	2017-08-31	Salk Institute For Biological Studies	Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
WO2018111767A1 (en)	2016-12-12	2018-06-21	Salk Institute For Biological Studies	Tumor-targeting synthetic adenoviruses and uses thereof
AU2019251356B2 (en)	2018-04-09	2025-06-12	Salk Institute For Biological Studies	Oncolytic adenovirus compositions with enhanced replication properties

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601676B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Procede de preparation du taxol et du desacetyl-10 taxol
FR2601675B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629818B1 (fr) *	1988-04-06	1990-11-16	Centre Nat Rech Scient	Procede de preparation du taxol
FR2662440B1 (fr) *	1990-05-22	1992-07-31	Rhone Poulenc Sante	Procede de preparation stereoselective de derives de la phenylisoserine.
FR2662441B1 (fr)	1990-05-22	1992-10-23	Rhone Poulenc Sante	Procede de preparation enantioselective de derives de la phenylisoserine.
WO1993000926A1 (en)	1991-07-02	1993-01-21	Children's Medical Center Corporation	Treatment of periodontal disease with protease inhibitors
FR2678833B1 (fr)	1991-07-08	1995-04-07	Rhone Poulenc Rorer Sa	Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
FR2698543B1 (fr) *	1992-12-02	1994-12-30	Rhone Poulenc Rorer Sa	Nouvelles compositions à base de taxoides.
FR2698871B1 (fr) *	1992-12-09	1995-02-24	Rhone Poulenc Rorer Sa	Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2705361B1 (fr)	1993-05-18	1995-08-04	Centre Nat Rech Scient	Vecteurs viraux et utilisation en thérapie génique.
FR2705686B1 (fr) *	1993-05-28	1995-08-18	Transgene Sa	Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
FR2706486B1 (fr)	1993-06-16	1995-09-01	Rhone Poulenc Rorer Sa	Séquences nucléiques, vecteurs les contenant, compositions pharmaceutiques et utilisations thérapeutiques.
WO1995002697A1 (fr)	1993-07-13	1995-01-26	Rhone-Poulenc Rorer S.A.	Vecteurs adenoviraux defectifs et utilisation en therapie genique
WO1995003400A1 (en)	1993-07-23	1995-02-02	Johns Hopkins University School Of Medicine	Recombinationally targeted cloning in yeast artificial chromosomes
US7252989B1 (en)	1994-04-04	2007-08-07	Board Of Regents, The University Of Texas System	Adenovirus supervector system
FR2722191B1 (fr)	1994-07-08	1996-08-23	Rhone Poulenc Rorer Sa	Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
FR2724945B1 (fr)	1994-09-27	1996-12-27	Centre Nat Rech Scient	Vecteurs viraux et utilisation en therapie genique
IL116816A (en)	1995-01-20	2003-05-29	Rhone Poulenc Rorer Sa	Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
FR2730504B1 (fr)	1995-02-13	1997-03-28	Rhone Poulenc Rorer Sa	Procede de preparation de genomes d'adenovirus recombinants
US5652224A (en) *	1995-02-24	1997-07-29	The Trustees Of The University Of Pennsylvania	Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
US5863904A (en) *	1995-09-26	1999-01-26	The University Of Michigan	Methods for treating cancers and restenosis with P21
CA2283090A1 (en) *	1997-02-20	1998-08-27	Hepavec Aktiengesellschaft Fur Gentherapie	Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
KR20010020342A (ko) *	1997-04-28	2001-03-15	자끄 사비나	종양치료용 맥관형성 길항제의 아데노바이러스-매개 종양내 전달방법
US6022708A (en) *	1998-02-26	2000-02-08	Genentech, Inc.	Fused
FR2778670B1 (fr)	1998-05-18	2002-12-13	Rhone Poulenc Rorer Sa	Methodes et compositions pour la production de particules virales
WO2000012738A1 (en)	1998-08-27	2000-03-09	Aventis Pharma S.A.	Targeted adenovirus vectors for delivery of heterologous genes
FR2794771B1 (fr) *	1999-06-11	2001-08-10	Aventis Pharma Sa	Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)

1999
- 1999-06-11 FR FR9907449A patent/FR2794771B1/fr not_active Expired - Fee Related
2000
- 2000-06-08 AU AU55407/00A patent/AU782934B2/en not_active Ceased
- 2000-06-08 KR KR1020017015802A patent/KR100708949B1/ko not_active Expired - Fee Related
- 2000-06-08 IL IL14618200A patent/IL146182A0/xx unknown
- 2000-06-08 EP EP00940476A patent/EP1187919B1/fr not_active Expired - Lifetime
- 2000-06-08 DE DE60037189T patent/DE60037189T2/de not_active Expired - Lifetime
- 2000-06-08 JP JP2001502790A patent/JP2003501107A/ja active Pending
- 2000-06-08 MX MXPA01012004A patent/MXPA01012004A/es unknown
- 2000-06-08 HU HU0201455A patent/HUP0201455A3/hu unknown
- 2000-06-08 CA CA002376735A patent/CA2376735A1/fr not_active Abandoned
- 2000-06-08 CN CNB008085900A patent/CN1259418C/zh not_active Expired - Fee Related
- 2000-06-08 WO PCT/FR2000/001594 patent/WO2000076450A2/fr active IP Right Grant
2009
- 2009-09-25 US US12/567,076 patent/US20100080775A1/en not_active Abandoned
2012
- 2012-07-02 US US13/540,421 patent/US8642028B2/en not_active Expired - Fee Related
- 2012-10-11 JP JP2012225794A patent/JP2013048626A/ja active Pending

Also Published As

Publication number	Publication date
DE60037189D1 (de)	2008-01-03
IL146182A0 (en)	2002-07-25
CN1408022A (zh)	2003-04-02
US20100080775A1 (en)	2010-04-01
US20120269773A1 (en)	2012-10-25
EP1187919B1 (fr)	2007-11-21
AU5540700A (en)	2001-01-02
KR100708949B1 (ko)	2007-04-18
KR20020028893A (ko)	2002-04-17
JP2003501107A (ja)	2003-01-14
JP2013048626A (ja)	2013-03-14
FR2794771B1 (fr)	2001-08-10
CN1259418C (zh)	2006-06-14
DE60037189T2 (de)	2008-10-09
US8642028B2 (en)	2014-02-04
WO2000076450A2 (fr)	2000-12-21
MXPA01012004A (es)	2002-05-06
CA2376735A1 (fr)	2000-12-21
WO2000076450A3 (fr)	2001-06-28
AU782934B2 (en)	2005-09-08
EP1187919A2 (fr)	2002-03-20
FR2794771A1 (fr)	2000-12-15
HUP0201455A2 (en)	2002-08-28

Publication	Publication Date	Title
IL130899A0 (en)	2001-01-28	Adenoviruses having altered hexon proteins
IL146182A0 (en)	2002-07-25	Recombinant adenoviruses for the sodium/iodide symporter (nis)
CZ20012876A3 (cs)	2002-06-12	SP-C analogy
GB0128994D0 (en)	2002-01-23	Peptides
IL142012A0 (en)	2002-03-10	Stomach polypeptide zsig28
GB9922283D0 (en)	1999-11-17	Adenoviral vectors
IL132105A0 (en)	2001-03-19	Caspase-8 interacting proteins
GB9923889D0 (en)	1999-12-08	Novel polypeptide
ZA993037B (en)	2000-03-06	Cheap clamp for external fixator.
EP1147130A4 (en)	2004-09-29	ALPHA-conotoxin PEPTIDE
GB9924951D0 (en)	1999-12-22	Novel polypeptide
EP1179540A4 (en)	2002-10-09	NEW POLYPEPTIDES
GB9924484D0 (en)	1999-12-15	Altered polypeptide aggregation
GB2371133B (en)	2004-08-04	E commerce system
IL144376A0 (en)	2002-05-23	Peptides
GB9918680D0 (en)	1999-10-13	Polypeptide
GB9923893D0 (en)	1999-12-08	Novel polypeptide
GB9923890D0 (en)	1999-12-08	Novel polypeptide
GB9924960D0 (en)	1999-12-22	Novel polypeptide
GB9929970D0 (en)	2000-02-09	Sodium channel proteins
IL149355A0 (en)	2002-11-10	Polypeptide corporation
GB9920288D0 (en)	1999-10-27	Dual clamp
GB9924956D0 (en)	1999-12-22	Novel polypeptide
ZA200200092B (en)	2003-03-26	Recombinant adenovirus.
SG76649A1 (en)	2000-11-21	Virtual marketplace

Legal Events

Date	Code	Title	Description
2009-03-02	FD9A	Lapse of provisional protection due to non-payment of fees